EPO publishes decision to revoke Boston Scientific’s stent patent
MLex Summary: The European Patent Office has today published its decision to revoke Boston Scientific’s patent for a stent design aimed at reducing inflammation, following a challenge by Biotronik. The ruling,...To view the full article, register now.
Already a subscriber? Click here to view full article